COVID-19 and Ehlers-Danlos Syndrome: The Dangers of the Spike Protein of SARS-CoV-2

Infect Disord Drug Targets. 2023;23(3):e040123212375. doi: 10.2174/1871526523666230104145108.

Ziad Fajloun^{1

2}, Christian Legros³, Jean-Marc Sabatier⁴

¹ Department of Biology, Faculty of Sciences 3, Lebanese University, Campus Michel Slayman Ras Maska, Tripoli 1352, Lebanon.
² Laboratory of Applied Biotechnology (LBA3B), Azm Center for Research in Biotechnology and its Applications, EDST, Lebanese University, Tripoli 1300, Lebanon.
³ College of Life Sciences, University of Angers, INSERM, CNRS, MITOVASC, Team 2 CarMe, SFR ICAT, Angers 49000, France.
⁴ College of Life Sciences, Aix-Marseille University, CNRS, INP, Inst Neurophysiopathol, Marseille 13385, France.

No abstract available

Publication types